DWQA Questions › Tag: clinical trials
Filter:AllOpenResolvedClosedUnanswered
A $100 million clinical study (ISCHEMIA) followed more than 5,000 men and women from 37 countries with severe but stable heart disease to assess the value of procedures to help their coronary artery disease. Was the ISCHEMIA clinical trial compromised by the interlopers to discourage use of stents and coronary bypass procedures?
ClosedNicola asked 3 years ago • 
348 views0 answers0 votes
There have been prominent announcements from the FDA about the inadvisability and dangers of people using ivermectin to treat COVID-19. Caution about taking pill formulations intended for large animals by humans is understandable, but this seems to have the same feel as the trashing of hydroxychloroquine early and often by the medical establishment exaggeration of possible side effects and even alteration of the data in clinical trials to make it falsely look both ineffective and highly toxic. Is that planned or underway to deliberately undercut further studies of ivermectin?
ClosedNicola asked 4 years ago • 
443 views0 answers0 votes
Will further clinical studies of fluvoxamine in patients with COVID-19 be suppressed by the US medical establishment as they have done for hydroxychloroquine?
ClosedNicola asked 4 years ago • 
412 views0 answers0 votes
In a preliminary study of adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration. There was clinical deterioration in 0 of 80 patients in the fluvoxamine group and in 6 of 72 patients in the placebo group (absolute difference, 8.7% [95% CI, 1.8%-16.4%] from survival analysis; log-rank P = .009). The fluvoxamine group had 1 serious adverse event and 11 other adverse events, whereas the placebo group had 6 serious adverse events and 12 other adverse events. Is this a worthwhile agent for COVID-19 management? How would it compare with hydroxychloroquine or ivermectin?
ClosedNicola asked 4 years ago • 
439 views0 answers0 votes
An osteopathic physician and frequent spokesperson on the Internet says there are at least 10 ways that the SARS-CoV-2 mRNA vaccines can cause serious side effects in human recipients. Is this the case, or an exaggeration? Why is she beating this drum?
ClosedNicola asked 4 years ago • 
653 views0 answers0 votes
Is there a danger that clinical trials of COVID-19 vaccines will be interfered with by the Extraterrestrial Alliance to show lack of effectiveness, even if the approach can work?
ClosedNicola asked 5 years ago • 
417 views0 answers0 votes
Is there a likelihood the Extraterrestrial Alliance will rig a vaccine trial to falsely show effectiveness, so it will be embraced by the masses, but useless, except to deliver locater chips?
ClosedNicola asked 5 years ago • 
447 views0 answers0 votes
Is the information on chlorine dioxide effectiveness for curing malaria accurate, that it was 100% effective, as described by Dr. Andreas Ludwig Kalcker?
ClosedNicola asked 5 years ago • 
502 views0 answers0 votes
A study just completed in the U.S. and Canada of 821 health care workers exposed to people with COVID-19 infections failed to show a statistically significant benefit of hydroxychloroquine in preventing infections (11.8% with hydroxychloroquine versus 14.3% of placebo group became ill). There was also no significant lessening of disease severity once they became symptomatic. How can the data be explained in view of your support for hydroxychloroquine use?
ClosedNicola asked 5 years ago • 
401 views0 answers0 votes
The New England Journal of Medicine just published a non-randomized study of hydroxychloroquine coupled with azithromycin in patients with moderate to severe COVID-19 infections, showing no benefit compared to a control group, using intubation or death as endpoints. Can you comment on the prospects for this therapy, in light of this study and your prior endorsement of this treatment?
ClosedNicola asked 5 years ago • 
393 views0 answers0 votes
Is the recent small study combining azithromycin with hydroxychloroquine in treating coronavirus COVID-19 accurate in reflecting significant clinical benefit due to both anti-inflammatory and antiviral replication activities? Will this be a valuable adjunct in reducing the impact of the pandemic?
ClosedNicola asked 5 years ago • 
531 views0 answers0 votes
Ask Question